Las Vegas, NV -- (SBWIRE) -- 12/04/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Integrated Device Technology Inc (NASDAQ:IDTI), Goodrich Petroleum Corporation (NYSE:GDP), Immunomedics, Inc. (NASDAQ:IMMU), Boyd Gaming Corporation (NYSE:BYD)
Integrated Device Technology Inc (NASDAQ:IDTI) managed to keep its gain at 2.36% on above-normal volume of 1.81M shares. The stock settled at $9.98 after floating in a range of $9.77 to $10.07. Its latest price has reached market capitalization of $1.51 billion. Its 52-week range has been $6.21 to $11.36. Integrated Device Technology, Inc. (IDT) designs, develops, manufactures and markets a broad range of low-power mixed signal semiconductor solutions for the advanced communications, computing and consumer industries. The Company operates in the Communications segment and the Computing and Consumer segment.
For How Long IDTI will fight for Profitability? Read This Trend Analysis report
Goodrich Petroleum Corporation (NYSE:GDP) traded up on a volume of 1.81 million, higher than its standard daily volume. Shares have gained 3.58% to $19.36. Over the last twelve months, the stock has gained 114.87% and faced a worst price of $7.95. Goodrich Petroleum Corporation is an independent oil and natural gas company engaged in exploration, development and production of oil and natural gas on properties primarily in Northwest Louisiana, East Texas and South Texas. It includes the Haynesville Shale and Cotton Valley Taylor Sand in Northwest Louisiana and East Texas, the Eagle Ford Shale and Buda Lime formations in South Texas and the Tuscaloosa Marine Shale in Southeast Louisiana and Southwest Mississippi. It owns interests in 401 producing oil and natural gas wells.
For How Long GDP’s Gloss will Attract Investors? Find out via this report
Immunomedics, Inc. (NASDAQ:IMMU) settled 4.49% higher at $4.42 on above-normal volume of 1.80M shares during the last trading day. The stock has its 12-month high at $7.35 and 52-week low price was $2.11. It traded in a range of $4.11 to $4.57 during the last trading day. Immunomedics, Inc. is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. The Company has developed a number of advanced technologies that allow the Company to create humanized antibodies that can be used either alone in unlabeled or naked form, or conjugated with radioactive isotopes, chemotherapeutics, cytokines or toxins, in each case to create targeted agents.
Why Should Investors Buy IMMU After the Recent Fall? Just Go Here and Find Out
In the last trading session, Boyd Gaming Corporation (NYSE:BYD) was down on low volume, trading at a volume of 1.78M versus its average daily volume of 2.97 million shares. At $11.04, the stock has attained market capitalization of 1.19 billion. Boyd Gaming Corporation (Boyd Gaming), incorporated in June 1988, is a multi-jurisdictional gaming company. The Company is an operator of 16 wholly owned gaming entertainment properties and one controlling interest in a limited liability company. It has gaming operations in Nevada, Illinois, Louisiana, Mississippi, Indiana and New Jersey.
Why Should Investors Buy BYD After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)